Health Service and Population Research Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.
ESRC Centre for Society and Mental Health, Institute of Psychiatry, Psychology and Neuroscience, King's College London, King's College London, London, United Kingdom.
JAMA Psychiatry. 2023 Jan 1;80(1):40-48. doi: 10.1001/jamapsychiatry.2022.3781.
Less than 10% of research on psychotic disorders has been conducted in settings in the Global South, which refers broadly to the regions of Latin America, Asia, Africa, and Oceania. There is a lack of basic epidemiological data on the distribution of and risks for psychoses that can inform the development of services in many parts of the world.
To compare demographic and clinical profiles of cohorts of cases and rates of untreated psychoses (proxy for incidence) across and within 3 economically and socially diverse settings in the Global South. Two hypotheses were tested: (1) demographic and clinical profiles of cases with an untreated psychotic disorder vary across setting and (2) rates of untreated psychotic disorders vary across and within setting by clinical and demographic group.
DESIGN, SETTING, AND PARTICIPANTS: The International Research Program on Psychotic Disorders in Diverse Settings (INTREPID II) comprises incidence, case-control, and cohort studies of untreated psychoses in catchment areas in 3 countries in the Global South: Kancheepuram District, India; Ibadan, Nigeria; and northern Trinidad. Participants were individuals with an untreated psychotic disorder. This incidence study was conducted from May 1, 2018, to July 31, 2020. In each setting, comprehensive systems were implemented to identify and assess all individuals with an untreated psychosis during a 2-year period. Data were analyzed from January 1 to May 1, 2022.
The presence of an untreated psychotic disorder, assessed using the Schedules for Clinical Assessment in Neuropsychiatry, which incorporate the Present State Examination.
Identified were a total of 1038 cases, including 64 through leakage studies (Kancheepuram: 268; median [IQR] age, 42 [33-50] years; 154 women [57.5%]; 114 men [42.5%]; Ibadan: 196; median [IQR] age, 34 [26-41] years; 93 women [47.4%]; 103 men [52.6%]; Trinidad: 574; median [IQR] age, 30 [23-40] years; 235 women [40.9%]; 339 men [59.1%]). Marked variations were found across and within settings in the sex, age, and clinical profiles of cases (eg, lower percentage of men, older age at onset, longer duration of psychosis, and lower percentage of affective psychosis in Kancheepuram compared with Ibadan and Trinidad) and in rates of untreated psychosis. Age- and sex-standardized rates of untreated psychoses were approximately 3 times higher in Trinidad (59.1/100 000 person-years; 95% CI, 54.2-64.0) compared with Kancheepuram (20.7/100 000 person-years; 95% CI, 18.2-23.2) and Ibadan (14.4/100 000 person-years; 95% CI, 12.3-16.5). In Trinidad, rates were approximately 2 times higher in the African Trinidadian population (85.4/100 000 person-years; 95% CI, 76.0-94.9) compared with the Indian Trinidadian (43.9/100 000 person-years; 95% CI, 35.7-52.2) and mixed populations (50.7/100 000 person-years; 95% CI, 42.0-59.5).
This analysis adds to research that suggests that core aspects of psychosis vary by historic, economic, and social context, with far-reaching implications for understanding and treatment of psychoses globally.
在全球南方(广义上指拉丁美洲、亚洲、非洲和大洋洲地区)进行的精神障碍研究中,不到 10%是在该地区进行的。在世界许多地区,缺乏关于精神障碍分布和发病风险的基本流行病学数据,无法为服务的发展提供信息。
比较全球南方 3 个具有不同经济和社会特征的环境中的病例队列的人口统计学和临床特征以及未治疗精神障碍的发病率(代表发病率)。提出了两个假设:(1)未经治疗的精神障碍病例的人口统计学和临床特征因环境而异;(2)未经治疗的精神障碍的发病率因临床和人口统计学因素在不同环境和同一环境内而有所不同。
设计、设置和参与者:国际不同环境下精神障碍研究计划(INTREPID II)包括在全球南方 3 个国家(印度的坎奇普尔区、尼日利亚的伊巴丹和特立尼达北部)的不同环境中的未治疗精神障碍的发病率、病例对照和队列研究。参与者为未经治疗的精神障碍患者。这项发病率研究于 2018 年 5 月 1 日至 2020 年 7 月 31 日进行。在每个环境中,都实施了全面的系统来识别和评估在 2 年期间所有未经治疗的精神障碍患者。数据分析于 2022 年 1 月 1 日至 5 月 1 日进行。
使用包括当前状态检查在内的临床评估量表来评估未经治疗的精神障碍的存在。
共确定了 1038 例病例,其中通过泄漏研究确定了 64 例(坎奇普尔区:268 例;中位数[IQR]年龄,42[33-50]岁;154 名女性[57.5%];114 名男性[42.5%];伊巴丹:196 例;中位数[IQR]年龄,34[26-41]岁;93 名女性[47.4%];103 名男性[52.6%];特立尼达:574 例;中位数[IQR]年龄,30[23-40]岁;235 名女性[40.9%];339 名男性[59.1%])。在病例的性别、年龄和临床特征(例如,男性比例较低、发病年龄较大、精神病持续时间较长、情感性精神病比例较低)以及未治疗精神病的发病率方面,跨环境和同一环境内都存在明显差异。特立尼达的未治疗精神病标准化发病率(59.1/100000 人年;95%CI,54.2-64.0)大约是坎奇普尔区(20.7/100000 人年;95%CI,18.2-23.2)和伊巴丹(14.4/100000 人年;95%CI,12.3-16.5)的近 3 倍。在特立尼达,非洲裔特立尼达人的发病率(85.4/100000 人年;95%CI,76.0-94.9)大约是印度裔特立尼达人(43.9/100000 人年;95%CI,35.7-52.2)和混血儿(50.7/100000 人年;95%CI,42.0-59.5)的近 2 倍。
这项分析增加了研究结果,表明精神障碍的核心方面因历史、经济和社会背景而异,对全球范围内对精神障碍的理解和治疗具有深远的影响。